AJCN EB Program 2010 Early Registration
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anderson, T. W.
Right arrow Articles by Reid, D. B. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anderson, T. W.
Right arrow Articles by Reid, D. B. W.
Agricola
Right arrow Articles by Anderson, T. W.
Right arrow Articles by Reid, D. B. W.

American Journal of Clinical Nutrition, Vol 27, 1174-1178, Copyright © 1974 by The American Society for Clinical Nutrition, Inc.

A double-blind trial of vitamin E in angina pectoris

Terence W. Anderson B.M., B.Ch., Ph.D.1 and D. B. William Reid M.Sc.1

1 From the Department of Epidemiology and Biometrics, School of Hygiene, University of Toronto, Toronto, Ontario, Canada

The claim that large doses of vitamin E can relieve the symptoms of angina pectoris has been strenuously debated for over 20 years. The few clinical trials that were carried out (around 1950) gave negative results, but these trials have been criticized on the grounds of small numbers, poor design, or inadequate dosage. The present trial was therefore carried out on 50 patients, using a randomized double-blind design, and a daily dosage of 3,200 IU of vitamin E or placebo. The results were not conclusive.




This article has been cited by other articles:


Home page
 Cancer Res.Home page
T. Hahn, L. Szabo, M. Gold, L. Ramanathapuram, L. H. Hurley, and E. T. Akporiaye
Dietary Administration of the Proapoptotic Vitamin E Analogue {alpha}-Tocopheryloxyacetic Acid Inhibits Metastatic Murine Breast Cancer
Cancer Res., October 1, 2006; 66(19): 9374 - 9378.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
J. N Hathcock, A. Azzi, J. Blumberg, T. Bray, A. Dickinson, B. Frei, I. Jialal, C. S Johnston, F. J Kelly, K. Kraemer, et al.
Vitamins E and C are safe across a broad range of intakes
Am. J. Clinical Nutrition, April 1, 2005; 81(4): 736 - 745.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
E. R. Miller III, R. Pastor-Barriuso, D. Dalal, R. A. Riemersma, L. J. Appel, and E. Guallar
Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
Ann Intern Med, January 4, 2005; 142(1): 37 - 46.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
C. D. Morris and S. Carson
Routine Vitamin Supplementation To Prevent Cardiovascular Disease: A Summary of the Evidence for the U.S. Preventive Services Task Force
Ann Intern Med, July 1, 2003; 139(1): 56 - 70.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
J. M. ROOB, G. KHOSCHSORUR, A. TIRAN, J. H. HORINA, H. HOLZER, and B. M. WINKLHOFER-ROOB
Vitamin E Attenuates Oxidative Stress Induced by Intravenous Iron in Patients on Hemodialysis
J. Am. Soc. Nephrol., March 1, 2000; 11(3): 539 - 549.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
M. Grundman
Vitamin E and Alzheimer disease: the basis for additional clinical trials1
Am. J. Clinical Nutrition, February 1, 2000; 71(2): 630s - 636s.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
D. G. Meyers, P. A. Maloley, and D. Weeks
Safety of Antioxidant Vitamins
Arch Intern Med, May 13, 1996; 156(9): 925 - 935.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1974 by The American Society for Nutrition